Latest

``` Google Labs has launched an experimental application called Dreambeans, which uses artificial intelligence technology to integrate users’ Gmail, Calendar, Photos and other Google product data, generating personalized story content daily. Its goal is to help users break free from endless scrolling and focus on what truly matters—people and events.

As SpaceX approaches the largest IPO in history, multiple senior U.S. government officials have been revealed to hold shares in the company or its affiliates. This deeply intertwined web of interests is raising widespread concerns about potential conflicts of interest. According to Bloomberg, based on the latest publicly released

``` The expansion momentum of global artificial intelligence infrastructure continues to extend into the Asia-Pacific region. AI cloud service provider IREN announced that it has signed an 800MW transmission connection agreement in South Australia, marking the company’s official expansion of its data center business into the Asia-Pacific region. According to

``` John Williams, President of the Federal Reserve Bank of New York, said that the current U.S. monetary policy is appropriately positioned, but he believes there is no clear direction for future interest rate movements. Williams said in an interview with Yahoo Finance on Wednesday: "Monetary policy is in

``` The EU unveiled its most comprehensive technology sovereignty strategy to date on Wednesday, aiming to reduce reliance on US technology supply chains. According to reports, the strategy covers key areas such as semiconductors, artificial intelligence, and cloud computing. Core measures include the Cloud and AI Development Act (CADA) and Chip

Navitas Semiconductor’s stock price surged significantly in pre-market trading, becoming the latest beneficiary of the AI infrastructure investment boom. The company announced a collaboration with Nvidia’s MGX ecosystem to jointly advance the construction of 800 VDC AI infrastructure, boosting market sentiment. On May 29, the company participated in

``` A historic breakthrough has been achieved in the global field of pancreatic cancer treatment. The innovative drug Daraxonrasib, developed by RedMed, has, in the latest phase 3 clinical trial, increased the survival time for patients with advanced pancreatic cancer to 13.2 months, nearly doubling the 6.7 months achieved